Plain-English translation of NCT06487403 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether the timing of radiation therapy affects how well it works against head and neck squamous cell carcinoma. You would receive radiation treatment on one of two schedules—either a standard approach or a newer delayed approach—while researchers take MRI scans and small tissue samples throughout your treatment to track how your tumor and immune system respond.
Doctors want to understand if changing when certain parts of radiation are delivered can improve outcomes and reduce side effects. This research may help us learn whether delaying treatment to some areas helps the body's natural defenses fight cancer more effectively.
You likely qualify if…
You likely don't qualify if…
You would come to the hospital for radiation therapy visits over several weeks. Before treatment begins, you'll have an MRI scan and a small biopsy (tissue sample) taken from your tumor in the clinic. During week 2 of your treatment, you'll have another MRI scan and another biopsy. You may have a third biopsy and scan in week 4 if you're tolerating treatment well. Before each biopsy, you'll take an oral medication called pimonidazole, and you'll also have blood drawn at each biopsy visit so researchers can study your immune response.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Canada